4.5 Article

Potential efficacy of dopamine loaded-PVP/PAA nanogel in experimental models of Parkinsonism: Possible disease modifying activity

Related references

Note: Only part of the references are listed.
Article Engineering, Chemical

Preparation of water dispersible, fluorescent Ag-PAA-PVP hybrid nanogels and their optical properties

Yin Ding et al.

ADVANCED POWDER TECHNOLOGY (2014)

Review Chemistry, Physical

Radiation-induced synthesis of nanogels based on poly(N-vinyl-2-pyrrolidone)-A review

Slawomir Kadlubowski

RADIATION PHYSICS AND CHEMISTRY (2014)

Article Biochemistry & Molecular Biology

Methotrexate-loaded chitosan nanogels as 'Trojan Horses' for drug delivery to brain: Preparation and in vitro/in vivo characterization

Amir Azadi et al.

INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2013)

Review Pharmacology & Pharmacy

Supramolecular devices to improve the treatment of brain diseases

Donatella Paolino et al.

DRUG DISCOVERY TODAY (2011)

Article Pharmacology & Pharmacy

Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery

Adriana Trapani et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2011)

Review Polymer Science

Polymer nanoparticles: Preparation techniques and size-control parameters

J. Prasad Rao et al.

PROGRESS IN POLYMER SCIENCE (2011)

Article Pharmacology & Pharmacy

Design, biometric simulation and optimization of a nano-enabled scaffold device for enhanced delivery of dopamine to the brain

Samantha Pillay et al.

INTERNATIONAL JOURNAL OF PHARMACEUTICS (2009)

Article Neurosciences

A highly reproducible rotenone model of Parkinson's disease

Jason R. Cannon et al.

NEUROBIOLOGY OF DISEASE (2009)

Review Biotechnology & Applied Microbiology

Characterization of nanoparticles for therapeutics

Jennifer B. Hall et al.

NANOMEDICINE (2007)

Review Medicine, Research & Experimental

Diagnosis and treatment of Parkinson disease: molecules to medicine

Joseph M. Savitt et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Medicine, General & Internal

Neuroprotection in Parkinson disease - Mysteries, myths, and misconceptions

AHV Schapira et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)

Article Behavioral Sciences

L-DOPA reverses the hypokinetic behaviour and rigidity in rotenone-treated rats

M Alam et al.

BEHAVIOURAL BRAIN RESEARCH (2004)

Review Cell Biology

Biomarkers of neurodegenerative disorders: How good are they?

V Rachakonda et al.

CELL RESEARCH (2004)

Article Behavioral Sciences

Possible mechanism of action in melatonin attenuation of haloperidol-induced orofacial dyskinesia

PS Naidu et al.

PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2003)

Article Geriatrics & Gerontology

Mouse models of α-synucleinopathy and Lewy pathology

B Sommer et al.

EXPERIMENTAL GERONTOLOGY (2000)

Article Neurosciences

Chronic systemic pesticide exposure reproduces features of Parkinson's disease

R Betarbet et al.

NATURE NEUROSCIENCE (2000)